MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

por Maria, Naomi I, Brkic, Zana, Waris, Matti, van Helden-Meeuwsen, Cornelia G, Heezen, Kim, van de Merwe, Joop P, van Daele, Paul L, Dalm, Virgil A S H, Drexhage, Hemmo A, Versnel, Marjan A
Publicado 2014

Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma

por de Hoog, Joeri, Dik, Willem A., Lu, Lucy, Heezen, Kim C., ten Berge, Josianne C., Swagemakers, Sigrid M. A., van der Spek, Peter J., van Dongen, Jacques J. M., van der Velden, Vincent H. J., Rothova, Aniki, Langerak, Anton W.
Publicado 2019

Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma

por Mulder, Evalyn E.A.P., Damman, Jeffrey, Verver, Daniëlle, van der Veldt, Astrid A.M., Tas, Sam, Khemai-Mehraban, Tamana, Heezen, Kim C., Wouters, Roxane A., Verhoef, Cornelis, Verjans, Georges M.G.M., Langerak, Anton W., Grünhagen, Dirk J., Mooyaart, Antien L.
Publicado 2022

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation

por Melsen, Janine E., van Ostaijen-ten Dam, Monique M., van den Akker, Erik B., Welters, Marij J. P., Heezen, Kim C., Pico-Knijnenburg, Ingrid, Kolijn, P. Martijn, Bredius, Robbert G. M., van Doorn, Remco, Langerak, Anton W., Schilham, Marco W., Lankester, Arjan C.
Publicado 2022

Rapid Low-Cost Microarray-Based Genotyping for Genetic Screening in Primary Immunodeficiency

por Suratannon, Narissara, van Wijck, Rogier T. A., Broer, Linda, Xue, Laixi, van Meurs, Joyce B. J., Barendregt, Barbara H., van der Burg, Mirjam, Dik, Willem A., Chatchatee, Pantipa, Langerak, Anton W., Swagemakers, Sigrid M. A., Goos, Jacqueline A. C., Mathijssen, Irene M. J., Dalm, Virgil A. S. H., Suphapeetiporn, Kanya, Heezen, Kim C., Drabwell, Jose, Uitterlinden, André G., van der Spek, Peter J., van Hagen, P. Martin
Publicado 2020